Post-Market Data Collection to Evaluate the Performance of the Synergy Disc®
Condition(s) studied
Investigational drug(s) / intervention(s)
Synergy cervical spine disc replacement: motion preservation disc
Study summary
This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.
Eligibility
Primary outcome measure(s)
- Neck Disability Index (NDI) — 12 months
Neck disability Index improvement of \>15 pts (out of 100) in subjects by 12 months post operative compared with baseline. A lower score is a better score. - Device Related or Device Procedure Related Adverse Events — 12 months
Absence of major device related adverse events defined as radiographic failure, neurologic failure or failure by adverse event
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Royal Orthopaedic Hospital | Birmingham | United Kingdom | Recruiting |
| Kings College Hospital | London | United Kingdom | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06383962 on ClinicalTrials.gov ↗ ← All trials in the UK